Low-dose IL-2 therapy-a complex scenario that remains to be further explored

Jens Y. Humrich; Gabriela Riemekasten

doi:10.1038/nrrheum.2017.71

Low-dose IL-2 therapy-a complex scenario that remains to be further explored

Jens Y. Humrich, Gabriela Riemekasten^*

^*Corresponding author for this work

Department of Rheumatology and Clinical Immunology

9 Citations (Scopus)

Original language	English
Journal	Nature Reviews Rheumatology
Volume	13
Issue number	6
Pages (from-to)	386
Number of pages	1
ISSN	1759-4790
DOIs	https://doi.org/10.1038/nrrheum.2017.71
Publication status	Published - 01.06.2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.1038/nrrheum.2017.71

Cite this

@article{833236f2c0b343f2b5462eaba3c8698f,

title = "Low-dose IL-2 therapy-a complex scenario that remains to be further explored",

author = "Humrich, \{Jens Y.\} and Gabriela Riemekasten",

year = "2017",

month = jun,

day = "1",

doi = "10.1038/nrrheum.2017.71",

language = "English",

volume = "13",

pages = "386",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Research",

number = "6",

}

TY - JOUR

T1 - Low-dose IL-2 therapy-a complex scenario that remains to be further explored

AU - Humrich, Jens Y.

AU - Riemekasten, Gabriela

PY - 2017/6/1

Y1 - 2017/6/1

UR - https://www.scopus.com/pages/publications/85019713412

U2 - 10.1038/nrrheum.2017.71

DO - 10.1038/nrrheum.2017.71

M3 - Letters

C2 - 28490788

AN - SCOPUS:85019713412

SN - 1759-4790

VL - 13

SP - 386

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 6

ER -

Low-dose IL-2 therapy-a complex scenario that remains to be further explored

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this